(Q46974051)
Statements
1 reference
Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value? (English)
1 reference
1 reference
Lowell Schnipper
1 reference
Michael Goldstein
1 reference
1 October 2007
1 reference
1 reference
25
1 reference
4506-7; author reply 4508
1 reference
28
1 reference
Identifiers
1 reference
1 reference